Search
Close this search box.

Developments in Mannose-Based Treatments for Uropathogenic Escherichia coli-Induced Urinary Tract Infections

Author(s)

N.E. Hatton, Ch.G. Baumann & Martin A. Fascione

Sources

Developments in Mannose-Based Treatments for Uropathogenic Escherichia coli-Induced Urinary Tract Infections ChemBioChem 2020, 21, 1–18 doi.org/10.1002/cbic.202000406

fimh.png
During their lifetime almost half of the women will experience a symptomatic urinary tract infection (UTI) with a further half experiencing a relapse within six months. Currently UTIs with antibiotics, but increasing antibiotic resistance rates highlight the need for new treatments. Uropathogenic Escherichia coli (UPEC) is responsible for the majority of symptomatic UTI cases and thus has become a key pathological target. Adhesion of type one pilus subunit FimH at the surface of UPEC strains to mannose-saturated oligosaccharides located on the urothelium is critical to pathogenesis. Since the identification of FimH as a therapeutic target in the late 1980s, a substantial body of research has been generated focusing on the development of FimH-targeting mannose-based anti-adhesion therapies. The review discusses the design of different classes of these mannose-based compounds and their utility and potential as UPEC therapeutics.

Latest news

In 2024, several human infections with highly pathogenic clade 2.3.4.4b bovine influenza H5N1 viruses in...

DIONYSUS is a database of protein-carbohydrate interfaces annotated according to proteins and carbohydrates’ structural, chemical...

Cholera toxin (CT) is the etiological agent of cholera. The authors report that multiple classes...

As an abundant agricultural and forestry biomass resource, hemicelluloses are hard to effectively degrade and...